Differential effect of subchronic dexamethasone treatment on serotonin-2 and beta-adrenergic receptors in the rat cerebral cortex and hippocampus

Neurosci Lett. 1993 Jun 11;155(2):195-8. doi: 10.1016/0304-3940(93)90706-q.

Abstract

The effect of the 10-day dexamethasone administration on serotonin-2 (5-HT2) and beta-adrenergic receptor binding sites was evaluated in rat cerebral cortex and hippocampus. The dexamethasone treatment (1, 2 and 5 mg/kg) significantly increased the density of the 5-HT2 receptor binding sites in a dose-dependent manner, whereas a decreased density of beta-adrenergic receptor binding sites was observed in rat cortex. In contrast, there were no significant differences in the densities of the 5-HT2 or beta-adrenergic receptor binding sites in rat hippocampus using dexamethasone. The results suggest that dexamethasone differentially modulates the 5-HT2 and beta-adrenergic receptor binding sites in rat brain.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Chemistry / drug effects*
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Dexamethasone / administration & dosage
  • Dexamethasone / pharmacology*
  • Down-Regulation / drug effects
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Ketanserin / metabolism
  • Kinetics
  • Male
  • Organ Specificity
  • Propanolamines / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, beta / drug effects*
  • Receptors, Glucocorticoid / classification
  • Receptors, Glucocorticoid / drug effects
  • Receptors, Glucocorticoid / physiology*
  • Receptors, Serotonin / drug effects*
  • Up-Regulation / drug effects

Substances

  • Propanolamines
  • Receptors, Adrenergic, beta
  • Receptors, Glucocorticoid
  • Receptors, Serotonin
  • dexamethasone receptor
  • Dexamethasone
  • Ketanserin
  • CGP 12177